Showing results (321-330 of 1,375) with videos related to

Sort By:
Pageof 138
Neuro-Oncology Advances|March 27, 2026
Disturbance of functional connectivity in patients with low grade glioma is associated with worse progression-free survivalVeit M Stoecklein, Stephan Wunderlich, Jonathan Weller, et al.
Neuro-Oncology Advances|March 27, 2026
Long-term outcome of nimustine-based chemotherapy for oligodendrogliomaNobuhiro Hata, Ryosuke Otsuji, Daisuke Kuga, et al.
Neuro-Oncology Advances|March 27, 2026
Tumor resection in glioblastoma mouse models: Surgical techniques and translational potentialJulie Van Nieuwenhuyze, Aaron Ziani Zeryouh, Stéphanie De Vleeschauwer, et al.
Neuro-Oncology Advances|April 30, 2026
A new hope: Clinical advances in targeted therapies for pediatric diffuse midline gliomaJoshua Zhu, Maria Tsoli, Jean Bertoldo, et al.
Neuro-Oncology Advances|March 30, 2026
Disrupted transporter protein expression and cell-specific localization reveal neurovascular unit remodeling in human glioblastomaXun Bao, Yuanyuan Jiang, Beth Hermes, et al.
Neuro-Oncology Advances|March 30, 2026
Effects of short- and long-term mutant IDH1 inhibition on radiosensitivity across genetically diverse patient-derived IDH1-mutant glioma cellsYosuke Kitagawa, Logan D Muzyka, Ami Kobayashi, et al.
Neuro-Oncology Advances|April 17, 2026
Automatic longitudinal assessment of brain metastases improves detection of disease progressionDavid Weiss, Khaled Bousabarah, Nazanin Maleki, et al.
Neuro-Oncology Advances|April 24, 2026
Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trialByram H Ozer, Adam L Cohen, Howard Colman, et al.
Neuro-Oncology Advances|March 25, 2026
Rare germline variants contribute to glioma predisposition: Whole-genome analysis of a regional cohort of glioma patientsAdam Rosenbaum, Carl Wibom, Austin Hammermeister Suger, et al.
Neuro-Oncology Advances|March 19, 2026
Cerebrospinal fluid D-2-hydroxyglutarate for IDH-mutant glioma monitoringCecile Riviere-Cazaux, Yuta Suzuki, Zain Kizilbash, et al.
Pageof 138